http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006137839-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d202e9e866984fe229f6facc38f1d740 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b0a5d3f3e55198a0b53d5df3022aa7c8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3433eb999264e62bddf2b874e8497a7e http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6391d837c4abdd66f7a3212ef58eef7a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4152 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4152 |
| filingDate | 2005-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e8295b7ca082fca77ec8562511b3389 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f832ada1aa0d860f96962d5bd515a54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98d1da79fb6417c8f80d2e0d0b7ba43d |
| publicationDate | 2006-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2006137839-A2 |
| titleOfInvention | Combination therapy for treating cyclooxygenase-2 mediated diseases or conditions in patients at risk of thrombotic cardiovascular events |
| abstract | The invention encompasses a pharmaceutical composition comprising a therapeutically effective amount of a cyclooxygenase-2 selective inhibitor selected from rofecoxib and etoricoxib or a pharmaceutically acceptable salt thereof, and a therapeutically effective amount of a proton pump inhibitor selected from the group consisting of: omeprazole, lansoprazole, rabeprazole, pantoprazole, and esomeprazole, or a pharmaceutically acceptable salt of any of the aforementioned, in combination with a pharmaceutically acceptable carrier. The invention also encompasses a method for treating a cyclooxygenase-2 mediated disease or condition in a human patient at risk of a thrombotic cardiovascular event, wherein the patient is on aspirin therapy to reduce the risk of the thrombotic cardiovascular event, comprising administering to the patient this pharmaceutical composition. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2022273609-A1 |
| priorityDate | 2004-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 433.